Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-10-20
2000-06-20
Lambkin, Deborah C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514312, 514250, 514290, 514285, 514292, 546156, 546153, 546101, 546 62, 546 81, 544350, 544345, A61K 3147, A61K 31495, A61K 3144, C07D21516, C07D22106
Patent
active
060778504
ABSTRACT:
A class of benzopyrans, benzothiopyrans, dihydroquinolines, dihydronaphthalenes, and analogs thereof, is described for use in treating cyclooxygenase-2 mediated disorders. Compounds of particular interest are defined by Formula I'wherein X, A.sup.1, A.sup.2, A.sup.3, A.sup.4, R, R", R.sup.1 and R.sup.2 are as described in the specification.
REFERENCES:
patent: 4609744 (1986-09-01), Young et al.
patent: 4665202 (1987-05-01), Rimbault et al.
patent: 4761425 (1988-08-01), Girard et al.
patent: 4814346 (1989-03-01), Albert et al.
patent: 5004744 (1991-04-01), Weissmiller et al.
patent: 5082849 (1992-01-01), Huang et al.
patent: 5155130 (1992-10-01), Stanton et al.
patent: 5250547 (1993-10-01), Lochead et al.
patent: 5281720 (1994-01-01), Young et al.
patent: 5348976 (1994-09-01), Shibata et al.
patent: 5447943 (1995-09-01), Lochead et al.
patent: 5618843 (1997-04-01), Fisher et al.
patent: 5728713 (1998-03-01), Nilsson et al.
patent: 5728846 (1998-03-01), Vullgonda et al.
patent: 5731312 (1998-03-01), Mederski et al.
patent: 5807869 (1998-09-01), Furuya et al.
patent: 5811553 (1998-09-01), Farina et al.
patent: 5817674 (1998-10-01), Clemence et al.
patent: 5849798 (1998-12-01), Charpentier et al.
patent: 5869478 (1999-02-01), Ding et al.
patent: 5889021 (1999-03-01), Starke
patent: 5891878 (1999-04-01), Beasley et al.
Sabbaramaiah et al., Proc. Soc. Exp. Biol. Med., 216, 201:1997.
Hida et al., Anticancer Res., 19, 775-82:1998.
Wison, Cancer Res., 58, 2929-34:1998.
Buckman et al., Carcinogensis, 19, 729-29:1998.
Barnes et al., Lung Biol. Health Dis., 114, 11-27:1998.
M. Tsujii et al., Cell, 93, 705-16:1998.
Bustos, J. Clin. Inverst., 100, 1150-58:1997.
Bagetta et al., Biochem, Biophys. Res. Commun., 244, 819-24:1998.
Sandhya et al., Brain Res., 788, 233-31:1998.
Singer et al., Gastroenterology, 115, 297-306:1998.
Nogawa et al., Proc. Natl. Acad. Sci., 95, 10966-71:1998.
Nasjletti, Hypertension, 31, 194-200:1997.
Kawamori et al., Cancer Res., 58, 409-12:1998.
Miyamoto et al., Neuro Report, 9, 2331-4:1998.
Shoup, J. Trauma: inj., Infec., Crit care, 45, 215-21:1998.
Speir et al., Circ. Res., 83, 210-16:1998.
Bosch, Curr. Med. Res. Opin., 14, 29-38:1997.
Manrao et al., J. Indian. Counc. Chem., 12, 38-41:1996.
Loiodice et al, Tetrahdron, 6, 1001-11:1995.
Clemence et al., J. Med. Chem., 31, 1453-62:1988.
Lazer, et al., J. Med. Chem., 40, 980-89:1997.
Bunting et al., Can. J. Chem., 62, 1301-07:1984.
Ukhin et al., Izv. Akad. Nauk. Der. Khim., 5, 1222-28:1996.
Gupta et al., Indian J. Chem., 21B, 344-347:1982.
Rene and Royer, Eur. J. Med. Chem-Chim. Ther., 10, 72-78:1975.
Satoh et al., J. Med. Chem. 36, 3580-94:1993.
Bertenshaw Stephen R
Brown David L
Carter Jeffery S
Devadas Balekudru
Graneto Matthew J
Bulock Joseph W.
G.D. Searle & Co.
Lambkin Deborah C.
LandOfFree
Substituted benzopyran analogs for the treatment of inflammation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted benzopyran analogs for the treatment of inflammation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted benzopyran analogs for the treatment of inflammation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1853921